Collegium Pharmaceutical Inc’s recent filing unveils that its EVP & Chief Financial Officer Tupper Colleen unloaded Company’s shares for reported $0.19 million on Mar 21 ’25. In the deal valued at $30.03 per share,6,396 shares were sold. As a result of this transaction, Tupper Colleen now holds 156,667 shares worth roughly $4.12 million.
Then, Tupper Colleen sold 1,206 shares, generating $36,181 in total proceeds. Upon selling the shares at $30.00, the EVP & Chief Financial Officer now owns 163,063 shares.
Before that, Dreyer Scott sold 18,881 shares. Collegium Pharmaceutical Inc shares valued at $566,983 were divested by the EVP & Chief Commercial Officer at a price of $30.03 per share. As a result of the transaction, Dreyer Scott now holds 103,613 shares, worth roughly $2.73 million.
Needham upgraded its Collegium Pharmaceutical Inc [COLL] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who increased its forecast for the stock in late July from “a Neutral” to “a Buy”. Jefferies also remained covering COLL and has increased its forecast on June 07, 2024 with a “Buy” recommendation from previously “Hold” rating. Piper Sandler revised its rating on May 10, 2024. It rated COLL as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of COLL
On Friday, Collegium Pharmaceutical Inc [NASDAQ:COLL] saw its stock jump 6.61% to $26.30. Over the last five days, the stock has lost -6.54%. Collegium Pharmaceutical Inc shares have fallen nearly -8.20% since the year began. Nevertheless, the stocks have fallen -30.77% over the past one year. While a 52-week high of $42.29 was reached on 01/10/25, a 52-week low of $23.23 was recorded on 04/10/25. SMA at 50 days reached $29.39, while 200 days put it at $32.88.
Levels Of Support And Resistance For COLL Stock
The 24-hour chart illustrates a support level at 25.07, which if violated will result in even more drops to 23.83. On the upside, there is a resistance level at 26.94. A further resistance level may holdings at 27.57. The Relative Strength Index (RSI) on the 14-day chart is 38.82, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.50, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 57.92%. Stochastics %K at 30.75% indicates the stock is a holding.
How much short interest is there in Collegium Pharmaceutical Inc?
A steep rise in short interest was recorded in Collegium Pharmaceutical Inc stocks on 2025-03-31, dropping by -0.88 million shares to a total of 4.53 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 5.41 million shares. There was a decline of -19.5%, which implies that there is a negative sentiment for the stock.
